![]() ![]() The Annual Meeting will be a completely virtual meeting of stockholders. These items of business are more fully described in the Proxy Statement accompanying this Notice. To conduct any other business properly brought before the meeting. Registered public accounting firm for our fiscal year ending December 31, 2021. To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent Terms until the 2024 Annual Meeting of Stockholders. To elect the three nominees for Class I director named in the accompanying proxy statement to serve for three-year You will be able to attend and participate in the Annual Meeting online by visiting where you will be able to listen to the meeting live, submit questions, and vote. Stockholders, and taking into account recent federal, state and local guidance that has been issued, we have determined that the Annual Meeting will be held in a virtual meeting format only, via the internet, with no physical in-person meeting. In light of the COVID-19 pandemic, for the safety of all of our people, including our Therapeutics, Inc., a Delaware corporation, to be held on Friday, June 4, 2021 at 8:30 a.m. You are cordially invited to attend the 2021 Annual Meeting of Shareholders (the ∺nnual Meeting) of Silverback Previous filing by registration statement number, or the Form or Schedule and the date of its filing.įorm, Schedule or Registration Statement No.: ![]() ![]() Proposed maximum aggregate value of transaction:įee paid previously with preliminary materials.Ĭheck box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. The amount on which the filing fee is calculated and state how it was determined): Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth Title of each class of securities to which transaction applies: Payment of Filing Fee (Check the appropriate box):įee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. (Name of Person(s) Filing Proxy Statement, if other than the Registrant) (Name of Registrant as Specified In Its Charter) Soliciting Material Pursuant to §240.14a-12 We look forward to representing you in this case.Proxy Statement Pursuant to Section 14(a) of theĬonfidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) During the course of this litigation, you authorize us to employ, share work and/or fees with other attorneys or law firms to prosecute your case. Should you choose to do so, we will never ask you to reimburse us directly for any legal fees or expenses. Should we obtain a favorable result, you authorize us to ask the court to award us compensation or seek reimbursement of expenses and up to one-third of any monetary class fund, or to negotiate and obtain a fee amount from defendants to be paid by the defendants, or its insurer or successor, but we will never ask you to pay any of the costs of this litigation.Īs the client you are entitled to direct the litigation in any way you deem proper, and may at any time order us to dismiss the case or opt-out. Regardless of the result, we will never ask you to directly pay for any attorneys’ fees or costs. We agree to advance all expenses in the litigation, which means that you are not liable or responsible to pay any of the expenses of the action, whether attorneys’ fees or costs. throughout the litigation and/or closing of the transaction. prior to the recent takeover announcement and that you must maintain ownership in Silverback Therapeutics, Inc. As a named plaintiff, you acknowledge that you owned shares in Silverback Therapeutics, Inc. and/or its board of directors or officers. This confirms that you have retained Monteverde & Associates PC to file an action with a complaint against Silverback Therapeutics, Inc. To start a Class Action lawsuit, please sign the Silverback Therapeutics, Inc. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |